Importer of Controlled Substances Application: Sigma Aldrich Co. LLC, 14291-14292 [2022-05318]

Download as PDF 14291 Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on February 2, 2022, Meridian Medical Technologies, LLC, 2555 Hermelin Drive, Saint Louis, Missouri 63144, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Morphine ......................... Drug code Schedule 9300 II The company plans to import the control substance for analytical and research purposes. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non- approved finished dosage forms for commercial sale. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–05291 Filed 3–11–22; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–981] Importer of Controlled Substances Application: Sigma Aldrich Co. LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Sigma Aldrich Co. LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 13, 2022. Such persons may also file a written request for a hearing on the application on or before April 13, 2022. ADDRESSES: DEA requires that all comments be submitted electronically through the Federal eRulemaking Portal, SUMMARY: which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. In accordance with 21 CFR 1301.34(a), this is notice that on January 21, 2022, Sigma Aldrich Co. LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118– 4103, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: jspears on DSK121TN23PROD with NOTICES1 Controlled substance Drug code Cathinone ............................................................................................................................................................................... Methcathinone ........................................................................................................................................................................ Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................... Gamma Hydroxybutyric Acid .................................................................................................................................................. Tetrahydrocannabinols ........................................................................................................................................................... 4-Bromo-2,5-dimethoxyamphetamine .................................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine ................................................................................................................................. 2,5-Dimethoxyamphetamine ................................................................................................................................................... 3,4-Methylenedioxyamphetamine ........................................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine .............................................................................................................................. 3,4-Methylenedioxymethamphetamine ................................................................................................................................... 4-Methoxyamphetamine ......................................................................................................................................................... Dimethyltryptamine ................................................................................................................................................................. N-Benzylpiperazine ................................................................................................................................................................ Heroin ..................................................................................................................................................................................... Normorphine ........................................................................................................................................................................... Amobarbital ............................................................................................................................................................................ Secobarbital ............................................................................................................................................................................ Nabilone ................................................................................................................................................................................. Phencyclidine ......................................................................................................................................................................... Ecgonine ................................................................................................................................................................................. Ethylmorphine ......................................................................................................................................................................... Levorphanol ............................................................................................................................................................................ Meperidine .............................................................................................................................................................................. Thebaine ................................................................................................................................................................................. Opium, powdered ................................................................................................................................................................... Levo-alphacetylmethadol ........................................................................................................................................................ VerDate Sep<11>2014 17:51 Mar 11, 2022 Jkt 256001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\14MRN1.SGM 14MRN1 1235 1237 1248 2010 7370 7391 7392 7396 7400 7404 7405 7411 7435 7493 9200 9313 2125 2315 7379 7471 9180 9190 9220 9230 9333 9639 9648 Schedule I I I I I I I I I I I I I I I I II II II II II II II II II II II 14292 Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic Tetrahydrocannabinols. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–05318 Filed 3–11–22; 8:45 am] BILLING CODE P successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on February 7, 2022, Perkinelmer, Inc., 120 East Dedham Street, Boston, Massachusetts 02118– 2852, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance DEPARTMENT OF JUSTICE Lysergic Acid Diethylamide ...... Thebaine ................................... Drug Enforcement Administration [Docket No. DEA–977] Importer of Controlled Substances Application: Perkinelmer, Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Perkinelmer, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 13, 2022. Such persons may also file a written request for a hearing on the application on or before April 13, 2022. ADDRESSES: The DEA requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been jspears on DSK121TN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:51 Mar 11, 2022 Jkt 256001 Drug code Schedule 7315 9333 I II The company plans to import the listed controlled substances for bulk manufacturing into radioactive formulations for sale to its customers for research purposes. Drug code 9333 (Thebaine) will be used to import the Thebaine derivative Diprenorphine. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Matthew J. Strait, Deputy Assistant Administrator. [FR Doc. 2022–05308 Filed 3–11–22; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–983] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Agriculture Technology Institute, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing SUMMARY: PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 13, 2022. ADDRESSES: DEA requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.’’ SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may submit electronic comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all E:\FR\FM\14MRN1.SGM 14MRN1

Agencies

[Federal Register Volume 87, Number 49 (Monday, March 14, 2022)]
[Notices]
[Pages 14291-14292]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05318]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-981]


Importer of Controlled Substances Application: Sigma Aldrich Co. 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Sigma Aldrich Co. LLC has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
April 13, 2022. Such persons may also file a written request for a 
hearing on the application on or before April 13, 2022.

ADDRESSES: DEA requires that all comments be submitted electronically 
through the Federal eRulemaking Portal, which provides the ability to 
type short comments directly into the comment field on the web page or 
attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for 
submitting comments. Upon submission of your comment, you will receive 
a Comment Tracking Number. Please be aware that submitted comments are 
not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, 
your comment has been successfully submitted and there is no need to 
resubmit the same comment. All requests for a hearing must be sent to: 
(1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 
Morrissette Drive, Springfield, Virginia 22152; and (2) Drug 
Enforcement Administration, Attn: DEA Federal Register Representative/
DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests 
for a hearing should also be sent to: Drug Enforcement Administration, 
Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 
22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on January 21, 2022, Sigma Aldrich Co. LLC, 3500 Dekalb 
Street, Saint Louis, Missouri 63118-4103, applied to be registered as 
an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
         Controlled substance            Drug code        Schedule
------------------------------------------------------------------------
Cathinone.............................        1235  I
Methcathinone.........................        1237  I
Mephedrone (4-Methyl-N-                       1248  I
 methylcathinone).
Gamma Hydroxybutyric Acid.............        2010  I
Tetrahydrocannabinols.................        7370  I
4-Bromo-2,5-dimethoxyamphetamine......        7391  I
4-Bromo-2,5-dimethoxyphenethylamine...        7392  I
2,5-Dimethoxyamphetamine..............        7396  I
3,4-Methylenedioxyamphetamine.........        7400  I
3,4-Methylenedioxy-N-ethylamphetamine.        7404  I
3,4-Methylenedioxymethamphetamine.....        7405  I
4-Methoxyamphetamine..................        7411  I
Dimethyltryptamine....................        7435  I
N-Benzylpiperazine....................        7493  I
Heroin................................        9200  I
Normorphine...........................        9313  I
Amobarbital...........................        2125  II
Secobarbital..........................        2315  II
Nabilone..............................        7379  II
Phencyclidine.........................        7471  II
Ecgonine..............................        9180  II
Ethylmorphine.........................        9190  II
Levorphanol...........................        9220  II
Meperidine............................        9230  II
Thebaine..............................        9333  II
Opium, powdered.......................        9639  II
Levo-alphacetylmethadol...............        9648  II
------------------------------------------------------------------------


[[Page 14292]]

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis. In reference 
to drug code 7370 (Tetrahydrocannabinols) the company plans to import 
synthetic Tetrahydrocannabinols. No other activity for this drug code 
is authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-05318 Filed 3-11-22; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.